Flexible application of in synthetic route 20028-53-9

After consulting a lot of data, we found that this compound(20028-53-9)Synthetic Route of C7H6ClNO can be used in many types of reactions. And in most cases, this compound has more advantages.

Synthetic Route of C7H6ClNO. The reaction of aromatic heterocyclic molecules with protons is called protonation. Aromatic heterocycles are more basic than benzene due to the participation of heteroatoms. Compound: 2-Amino-5-chlorobenzaldehyde, is researched, Molecular C7H6ClNO, CAS is 20028-53-9, about Discovery and Optimization of Quinolinone Derivatives as Potent, Selective, and Orally Bioavailable Mutant Isocitrate Dehydrogenase 1 (mIDH1) Inhibitors. Author is Lin, Jian; Lu, Wei; Caravella, Justin A.; Campbell, Ann Marie; Diebold, R. Bruce; Ericsson, Anna; Fritzen, Edward; Gustafson, Gary R.; Lancia, David R.; Shelekhin, Tatiana; Wang, Zhongguo; Castro, Jennifer; Clarke, Andrea; Gotur, Deepali; Josephine, Helen R.; Katz, Marie; Diep, Hien; Kershaw, Mark; Yao, Lili; Kauffman, Goss; Hubbs, Stephen E.; Luke, George P.; Toms, Angela V.; Wang, Liann; Bair, Kenneth W.; Barr, Kenneth J.; Dinsmore, Christopher; Walker, Duncan; Ashwell, Susan.

Mutations at the arginine residue (R132) in isocitrate dehydrogenase 1 (IDH1) are frequently identified in various human cancers. Inhibition of mutant IDH1 (mIDH1) with small mols. has been clin. validated as a promising therapeutic treatment for acute myeloid leukemia and multiple solid tumors. Herein, we report the discovery and optimization of a series of quinolinones to provide potent and orally bioavailable mIDH1 inhibitors with selectivity over wild-type IDH1. The X-ray structure of an early lead 24 in complex with mIDH1-R132H shows that the inhibitor unexpectedly binds to an allosteric site. Efforts to improve the in vitro and in vivo absorption, distribution, metabolism, and excretion (ADME) properties of 24 yielded a preclin. candidate 63. The detailed preclin. ADME and pharmacol. studies of 63 support further development of quinolinone-based mIDH1 inhibitors as therapeutic agents in human trials.

After consulting a lot of data, we found that this compound(20028-53-9)Synthetic Route of C7H6ClNO can be used in many types of reactions. And in most cases, this compound has more advantages.

Reference:
Tetrahydrofuran – Wikipedia,
Tetrahydrofuran | (CH2)3CH2O – PubChem